Break it Down: Quick access to quick ED fix from LTR Pharma

Stockheads

2024-12-12

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.

Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.

Tune in to get the latest.

While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.

Explore More

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2490713841"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2490713841\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2490713841?lang=zh_TW&edition=fundamental","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/12/LTP-1200x675-1-640x360.jpg","is_english":true,"pubTime":"2024-12-12 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490713841","market":"us","top_or_hot":-1,"title":"Break it Down: Quick access to quick ED fix from LTR Pharma","media":"Stockheads","content":"<html><body><div><div></div></div><p>Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.</p><p>In this episode, host Sarah Hughan tells all on <strong>LTR Pharma’s (ASX:LTP)</strong> online healthcare platform for Aussie men to access Spontan.</p><p>Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.</p><p>Tune in to get the latest.</p><p><i>While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.</i></p><div></div><div> <h2>Explore More</h2> <ul><li> <img decoding=\"async\" height=\"169\" sizes=\"(max-width: 300px) 100vw, 300px\" src=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg\" srcset=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg 300w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-1024x576.jpg 1024w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-768x432.jpg 768w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-640x360.jpg 640w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1.jpg 1200w\" width=\"300\"/> <span>Investor Guide: Health &amp; Biotech FY2025 featuring Tim Boreham</span> </li> </ul></div><div></div></body></html>","source":"stockheads_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Break it Down: Quick access to quick ED fix from LTR Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBreak it Down: Quick access to quick ED fix from LTR Pharma\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Stockheads</strong><span class=\"h-time small\">2024-12-12 11:08</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div><div></div></div><p>Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.</p><p>In this episode, host Sarah Hughan tells all on <strong>LTR Pharma’s (ASX:LTP)</strong> online healthcare platform for Aussie men to access Spontan.</p><p>Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.</p><p>Tune in to get the latest.</p><p><i>While LTR Pharma is a Stockhead advertiser, it did not sponsor this content.</i></p><div></div><div> <h2>Explore More</h2> <ul><li> <img decoding=\"async\" height=\"169\" sizes=\"(max-width: 300px) 100vw, 300px\" src=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg\" srcset=\"https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-300x169.jpg 300w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-1024x576.jpg 1024w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-768x432.jpg 768w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1-640x360.jpg 640w, https://stockhead.com.au/wp-content/uploads/2024/08/Health-and-Biotech-Investor-Guide-1200x675-1.jpg 1200w\" width=\"300\"/> <span>Investor Guide: Health &amp; Biotech FY2025 featuring Tim Boreham</span> </li> </ul></div><div></div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://stockhead.com.au/stockhead-tv/break-it-down/break-it-down-quick-access-to-quick-ed-fix-from-ltr-pharma/\">Stockheads</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://stockhead.com.au/stockhead-tv/break-it-down/break-it-down-quick-access-to-quick-ed-fix-from-ltr-pharma/","article_id":"2490713841","we_media_id":null,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/12/LTP-1200x675-1-640x360.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490713841","pubTimestamp":1733972931,"columns":[],"sourceInfo":{"source_id":"stockheads_stock","name":"Stockheads"},"weMediaInfo":null,"summary":"Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.In this episode, host Sarah Hughan tells all on LTR Pharma’s  online healthcare platform for Aussie men to access Spontan.Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.Tune in to get the latest.While LTR Pharma is a Stockhead advertiser, it did not sponsor this content. Explore More   Investor Guide: Health & Biotech FY2025 featuring Tim Boreham","collect":0,"end_time":0,"defaultTopTitle":"stockhead.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU2346227817.USD":"BGF SUSTAINABLE GLOBAL INFRASTRUCTURE \"A2\" (USD) ACC","BK4208":"复合型公用事业","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","ED":"爱迪生联合电气"},"translate_title":"分解：快速获取LTR Pharma的quick ED fix","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ED":1},"content_text":"Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.In this episode, host Sarah Hughan tells all on LTR Pharma’s (ASX:LTP) online healthcare platform for Aussie men to access Spontan.Spontan is a novel nasal spray designed to treat erectile dysfunction, and recent trials have shown a faster absorption than oral treatment.Tune in to get the latest.While LTR Pharma is a Stockhead advertiser, it did not sponsor this content. Explore More   Investor Guide: Health & Biotech FY2025 featuring Tim Boreham","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}